Long-term use of a nasopharyngeal airway for obstructive sleep apnea

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This long-term follow-up allows participants from the parent trial to continue using a nasopharyngeal airway device for obstructive sleep apnea while remaining under study-team oversight. The study team will maintain contact as needed and participants will receive clinical follow-up with their own physicians. At 12 months participants will complete sleep questionnaires to document symptoms, device tolerability, and ongoing use. Participants who were non-compliant in the parent study are excluded and continued device use is voluntary.

Why it matters

Who can join: the full rules

Inclusion Criteria:

-Participants who completed the parent study (HUM00179497) and wish to continue using the NPA-OSA device.

Exclusion Criteria:

* The participants who were non-compliant with the NPA-OSA device during their participation in the parent study.

Where it's running

• Michigan Medicine
  Ann Arbor, Michigan, United States Recruiting
• University of Michigan
  Ann Arbor, Michigan, United States Recruiting

Study contacts

• Principal investigator: Louise M O'Brien, PhD — University of Michigan
• Study coordinator: Zahra Nourmohammadi, PhD
• Email: znourmoh@med.umich.edu
• Phone: 734 936-9816

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered sleep staging and sleep apnea screening using multimodal wearable data

  This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07908160

• Jaw advancement with counterclockwise rotation for obstructive sleep apnea

  This trial tests whether jaw advancement surgery with counterclockwise rotation helps people with moderate to severe obstructive sleep apnea who can't tolerate CPAP breathe better and sleep more soundly.

  Recruiting Dalarna County Council, Sweden · Falun, Dalarna County · NCT07446634

• Eloralintide for people with obstructive sleep apnea who are overweight or obese

  This study will test whether the drug eloralintide helps adults with moderate-to-severe obstructive sleep apnea who are overweight or obese, whether they use PAP therapy or not.

  Recruiting at 100 sites Phase 3 Eli Lilly and Company · Cullman, Alabama and 114 other locations · NCT07369011

• How insomnia affects PAP use in children and teens with obstructive sleep apnea.

  This study will see if insomnia makes children and teens with obstructive sleep apnea less likely to stick with positive airway pressure (PAP) therapy.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07176767

• Does mouth opening change with quality of life after adenotonsillectomy in kids with type 1 OSA?

  This study tests whether improvements in mouth opening after adenotonsillectomy are linked to better quality of life in children with Type 1 Obstructive Sleep Apnea.

  Recruiting Groupe Adène · Saint-Jean-de-Védas · NCT06973928

• Obstructive sleep apnea and blood sugar control in adults with type 1 diabetes

  This project will try nightly CPAP to see if treating obstructive sleep apnea improves blood sugar control in adults with type 1 diabetes who use an insulin pump and continuous glucose monitoring.

  Recruiting University of Chicago · Chicago, Illinois · NCT06915831

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.